{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T19:28:59Z","timestamp":1792956539287,"version":"4.5.0"},"reference-count":9,"publisher":"Centers for Disease Control MMWR Office","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7316a1","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T10:21:09Z","timestamp":1714040469000},"page":"360-364","source":"Crossref","is-referenced-by-count":31,"title":["Use of Ebola Vaccines \u2014 Worldwide, 2021\u20132023"],"prefix":"10.15585","volume":"73","author":[{"given":"Ruth","family":"Kallay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena H.","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Muhoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Legand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Aberle-Grasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminata","family":"Bagayoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri B.","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Formenty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"key-10.15585\/mmwr.mm7316a1-202404250835-R1","unstructured":"World Health Organization Regional Office for Africa. Outbreaks and Emergencies Bulletin. Cit\u00e9 du Djou\u00e9, Brazzaville, Republic of the Congo: World Health Organization Regional Office for Africa; 2024. https:\/\/www.afro.who.int\/health-topics\/disease-outbreaks\/outbreaks-and-other-emergencies-updates?page=0"},{"key":"key-10.15585\/mmwr.mm7316a1-202404250835-R2","unstructured":"World Health Organization. Ebola virus disease vaccines. Geneva, Switzerland: World Health Organization; 2023. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/ebola-vaccines"},{"key":"key-10.15585\/mmwr.mm7316a1-202404250835-R3","unstructured":"Merck. U.S. FDA approves Merck\u2019s ERVEBO (Ebola Zaire Vaccine, Live) for use in children 12 months of age and older. [Press release]. Rahway, NJ: Merck; 2023. https:\/\/www.merck.com\/news\/u-s-fda-approves-mercks-ervebo-ebola-zaire-vaccine-live-for-use-in-children-12-months-of-age-and-older\/"},{"key":"key-10.15585\/mmwr.mm7316a1-202404250835-R4","unstructured":"World Health Organization. Meeting of the Strategic Advisory Group of Experts on Immunization, 22\u201324 March 2021: conclusions and recommendations. Geneva, Switzerland: World Health Organization; 2021. https:\/\/www.who.int\/publications\/i\/item\/meeting-of-the-strategic-advisory-group-of-experts-on-immunization-22-24-march-2021-conclusions-and-recommendations"},{"key":"key-10.15585\/mmwr.mm7316a1-202404250835-R5","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00819-8","article-title":"Case fatality risk among individuals vaccinated with rVSV\u0394G-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo","author":"Coulborn","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.mm7316a1-202404250835-R6","unstructured":"Gavi, The Vaccine Alliance. 500,000 doses of Ebola vaccine to be made available to countries for outbreak response. Geneva, Switzerland: Gavi, The Vaccine Alliance; 2021. https:\/\/www.gavi.org\/news\/media-room\/500000-doses-ebola-vaccine-be-made-available-countries-outbreak-response"},{"key":"key-10.15585\/mmwr.mm7316a1-202404250835-R7","unstructured":"UNICEF. Emergency stockpile availability report - Ebola vaccine. New York, NY: UNICEF; 2024. https:\/\/www.unicef.org\/supply\/documents\/emergency-stockpile-availability-report-ebola-vaccine"},{"key":"key-10.15585\/mmwr.mm7316a1-202404250835-R8","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.vaccine.2022.11.036","article-title":"Targeted preventive vaccination campaigns to reduce Ebola outbreaks: an individual-based modeling study.","volume":"41","author":"Bisanzio","year":"2023","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.mm7316a1-202404250835-R9","doi-asserted-by":"publisher","first-page":"e1455","DOI":"10.1016\/S2214-109X(20)30454-X","article-title":"Vaccination of contacts of Ebola virus disease survivors to prevent further transmission.","volume":"8","author":"Doshi","year":"2020","journal-title":"Lancet Glob Health"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T10:21:13Z","timestamp":1714040473000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/73\/wr\/mm7316a1.htm?s_cid=mm7316a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":9,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,4,25]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7316a1","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,25]]},"published":{"date-parts":[[2024,4,25]]}}}